Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V} -- Ignore unavailable to you. Want to Upgrade?

To: Micawber who wrote (62)	2/7/1999 9:40:00 PM
From: CPAMarty	Read Replies (1) \| Respond to of 423

Investors Business Daily has an interesting story on page A4 of the 2/8/99 edition on Sugen (SUGN). Seems like (to a layman anyway) they are into the many of the same areas as IMCL (cancer, angiogenesis, ok not exactly like); only SUGN's projects seem to be more diversified and behind (in terms of the level of trials) that of IMCL's. So why is SUGN trading at $17 while IMCL is under $11? Richard Van Den Broek from H & Q was quoted in the IBD article - therefore i assume H & Q follows - maybe the difference in price is better explained by analyst coverage than the science.

To: Micawber who wrote (62)	2/8/1999 8:55:00 PM
From: BRAVEHEART	Respond to of 423

Hi Gang, Thanks Brian for the link. What you describe with ISIP could be just basic typical biotech growing pains. I do hope to see ISIP succeed. The world needs newer novel discoveries which can lead to the treatment of disease and such. Marty I agree sometimes an analyst's opinion can make all the difference with a stock. That and well formulated PR. Tuck makes a few good points too which need be considered when comparing shareprices. By the way tuck thanks for the compliment. I'll admit I am not familiar with NZYM. I am however somewhat more familiar with LGND. I have followed LGND for some time. In fact I have targeted LGND on several occasions as an undervalued play. In so doing I have come to know Henry casually. I have admired Henry's enthusiasm and efforts over the years. I have visited both LGND threads and have learned considerably from Henry's posts. So if I haven't said so in the past. Thanks Henry for your candid answers to any questions I have had in the past. Mike excellent site: If there is an award for DD Mike you get my vote. Reprinted here so as to not be overlooked. fda.gov BEST WISHES LONE WOLF